BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7914175)

  • 1. Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic.
    Ulrik CS; Kok-Jensen A
    Eur Respir J; 1994 May; 7(5):1003-5. PubMed ID: 7914175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the bronchodilating effects of inhaled formoterol, salmeterol and salbutamol in asthmatic patients.
    Grembiale RD; Pelaia G; Naty S; Vatrella A; Tranfa CM; Marsico SA
    Pulm Pharmacol Ther; 2002; 15(5):463-6. PubMed ID: 12406669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-acting beta-2-agonists in the treatment of asthma].
    Rochat T
    Schweiz Med Wochenschr; 1994 Oct; 124(39):1714-9. PubMed ID: 7939538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of salmeterol and formoterol in attenuating airway responses to short-acting beta2-agonists.
    van Veen A; Weller FR; Wierenga EA; Jansen HM; Jonkers RE
    Pulm Pharmacol Ther; 2003; 16(3):153-61. PubMed ID: 12749831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma.
    Campbell LM
    Int J Clin Pract; 2002 Dec; 56(10):783-90. PubMed ID: 12510953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy with formoterol in the absence of a response to salmeterol: a review.
    Kottakis J; Wood R; Le Gros V; Della Cioppa G
    Int J Clin Pract; 2001 Sep; 55(7):476-9. PubMed ID: 11594259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bronchodilating effect of formoterol but not of salmeterol in two asthmatic patients.
    Noppen M; Vincken W
    Respiration; 2000; 67(1):112-3. PubMed ID: 10705276
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the relative efficacy of formoterol and salmeterol in asthmatic patients.
    Palmqvist M; Ibsen T; Mellén A; Lötvall J
    Am J Respir Crit Care Med; 1999 Jul; 160(1):244-9. PubMed ID: 10390407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of formoterol and salbutamol on bronchial hyperreactivity and beta-adrenoceptor density on lymphocytes in children with bronchial asthma.
    Kozlik-Feldmann R; von Berg A; Berdel D; Reinhardt D
    Eur J Med Res; 1996 Jul; 1(10):465-70. PubMed ID: 9438143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salmeterol vs. formoterol: a comparison of rapid bronchodilator effect in a randomized controlled trial.
    Singhania N; Dhamija R; Lodha R; Kabra SK
    Indian Pediatr; 2008 Mar; 45(3):225-8. PubMed ID: 18367770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma.
    Aziz I; Hall IP; McFarlane LC; Lipworth BJ
    J Allergy Clin Immunol; 1998 Mar; 101(3):337-41. PubMed ID: 9525449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma.
    Löfdahl CG; Chung KF
    Eur Respir J; 1991 Feb; 4(2):218-26. PubMed ID: 1675178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of long-acting beta-agonists.
    Johnson M
    Ann Allergy Asthma Immunol; 1995 Aug; 75(2):177-9. PubMed ID: 7648384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting beta 2-agonists. Role in primary care asthma treatment.
    D'Urzo AD
    Can Fam Physician; 1997 Oct; 43():1773-7. PubMed ID: 9356758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. State of the art in beta2-agonist therapy: a safety review of long-acting agents.
    Rabe KF
    Int J Clin Pract; 2003 Oct; 57(8):689-97. PubMed ID: 14627180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in specific airway resistance after powder inhalation of formoterol or salmeterol in moderate bronchial asthma].
    Sill V; Bartuschka B; Villiger B; Ortland C; Domej W
    Pneumologie; 1999 Jan; 53(1):4-9. PubMed ID: 10091511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross tolerance to salbutamol occurs independently of beta2 adrenoceptor genotype-16 in asthmatic patients receiving regular formoterol or salmeterol.
    Lee DK; Jackson CM; Bates CE; Lipworth BJ
    Thorax; 2004 Aug; 59(8):662-7. PubMed ID: 15282385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmeterol and formoterol: asthma aggravation. Use should be restricted.
    Prescrire Int; 2009 Aug; 18(102):166. PubMed ID: 19743580
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-acting inhaled beta 2-agonists in the management of asthma: recent advances and current recommendations.
    Redington AE; Rees PJ
    Int J Clin Pract; 1998 Oct; 52(7):482-6. PubMed ID: 10622090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.